الصفحة الرئيسية>>Signaling Pathways>> Chromatin/Epigenetics>> Histone Methyltransferase>>CARM1-IN-1

CARM1-IN-1 (Synonyms: Protein Arginine Methyltransferase 4/CoactivatorAssociated Arginine Methyltransferase 1 Inhibitor)

رقم الكتالوجGC34108

CARM1-IN-1 عبارة عن مثبط CARM1 قوي ومحدد (مرتبط بمنشطات arginine methyltransferase 1) مع IC50 يبلغ 8.6 ميكرومتر ؛ يُظهر نشاطًا منخفضًا جدًا مقابل PRMT1 و SET7 (IC50> 600 uM)

Products are for research use only. Not for human use. We do not sell to patients.

CARM1-IN-1 التركيب الكيميائي

Cas No.: 1020399-49-8

الحجم السعر المخزون الكميّة
10mM (in 1mL DMSO)
215٫00
متوفر
2mg
83٫00
متوفر
5mg
176٫00
متوفر
10mg
287٫00
متوفر
50mg
918٫00
متوفر

Tel:(909) 407-4943 Email: sales@glpbio.com

مراجعات العميل

بناء على آراء العملاء.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

CARM1-IN-1 is a potent and specific CARM1(Coactivator-associated arginine methyltransferase 1) inhibitor with IC50 of 8.6 uM; shows very low activity against PRMT1 and SET7(IC50 > 600 uM). IC50 value: 8.6 uM [1]Target: CRAM1 inhibitorin vitro: CARM1-IN-1(Cmp 7g) displayed high and selective CARM1 inhibition, with lower or no activity against a panel of different PRMTs or HKMTs. In human LNCaP cells, 7g showed a significant dose-dependent reduction of the PSA promoter activity.

[1]. Cheng D, et al. Novel 3,5-bis(bromohydroxybenzylidene)piperidin-4-ones as coactivator-associated arginine methyltransferase 1 inhibitors: enzyme selectivity and cellular activity. J Med Chem. 2011 Jul 14;54(13):4928-32.

مراجعات

Review for CARM1-IN-1

Average Rating: 5 ★★★★★ (Based on Reviews and 35 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for CARM1-IN-1

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.